patents
In order to foster innovation, HCmed foments intellectual property protection. Our patents include different aspects of our device structure and technologies, including mesh module, breathing sensors, cleaning methods, and wireless authentication systems. We assess intellectual property matters when engaging in CDMO and ensure Freedom to Operate for customized products.
HCmed's breath-actuated technology enables aerosolization of medication during inhalation only, avoiding excessive amounts of API being wasted during exhalation. Moreover, it prevents emission of fugitive aerosols that could otherwise be unintendedly inhaled by those surrounding users during their treatment.
HCmed has developed devices with connectivity functions and a demo application to link mesh nebulizers to mobile devices. The collected data can be used to monitor patient adherence as well as manage nebulization treatment.
Device activation has been incorporated to link the nebulizer to a specific formulation, reinforcing patient adherence. This close system also prevents the use of off-label drugs and controlled substances.
Novel platforms for your drug-nebulizer combination product:
We offer:
Our Partners:
At HCmed, we offer comprehensive aerosol characterization analytical services to support the development and optimization of inhalation products. Our experienced scientists and state-of-the-art laboratories ensure accurate and reliable data for regulatory submissions. We offer analytical support in compliance with Pharmacopoeia guidelines (EUP, USP).
Our extensive experience in aerosol testing includes:
We have expertise in conducting tests with: